3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
77
Stomach Neoplasms
14
Neoplasms
8
Neoplasm Metastasis
8
HER2-positive Breast Cancer
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Brain Neoplasms
4
Inflammatory Breast Neoplasms
3
Breast Neoplasms, Male
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Cardiotoxicity
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Solid Tumor
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Meningeal Neoplasms
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Blood Specimen Collection
2
Trastuzumab
1
Denosumab
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplastic Cells, Circulating
×
Trastuzumab
×
Clear all
NCT04168931
2023-01-17
GASTHER2
AC Camargo Cancer Center
Phase 2
Terminated
5 enrolled